A functional link between heme oxygenase-1 and tristetraprolin in the anti-inflammatory effects of nicotine

Free Radic Biol Med. 2013 Dec:65:1331-9. doi: 10.1016/j.freeradbiomed.2013.09.027. Epub 2013 Oct 2.

Abstract

Nicotine stimulates the cholinergic anti-inflammatory pathway and prevents excessive inflammation by inhibiting the release of inflammatory cytokines from macrophages. We have previously reported that heme oxygenase-1 (HO-1) and tristetraprolin (TTP) are induced by nicotine and mediate the anti-inflammatory function of nicotine in macrophages. However, it was not clear whether the two molecules are functionally linked. In this study, we sought to determine whether HO-1 associates with TTP to mediate the anti-inflammatory effects of nicotine. Inhibition of HO-1 activity or HO-1 expression attenuated the effects of nicotine on STAT3 activation, TTP induction, and TNF-α production in LPS-treated macrophages. Induction of HO-1 expression increased the level of TTP in the absence of nicotine. In an LPS-induced endotoxemia model, HO-1 deficiency blocked the effects of nicotine on the STAT3 phosphorylation, TTP induction, and LPS-induced TNF-α production in the liver. Downregulation of STAT3 by siRNA attenuated the effect of nicotine on TTP expression and TNF-α production but did not affect the nicotine-mediated induction of HO-1. In TTP knockout mice, nicotine treatment enhanced HO-1 expression and STAT3 activation but failed to inhibit LPS-induced TNF-α production. Our results suggest that HO-1 and TTP are functionally linked in mediating the anti-inflammatory effects of nicotine; HO-1 is necessary for the induction of TTP by nicotine. This novel nicotine-HO-1-TTP signaling pathway provides new possibilities for the treatment of inflammatory diseases.

Keywords: Anti-inflammatory effects; CoPP; ECL; Free radicals; HO-1; KO; LPS; Nicotine; STAT3; SnPP; TNF; TTP; ZnPP; cobalt protoporphyrin; enhanced chemiluminescence; heme oxygenase-1; knockout; lipopolysaccharide; signal transducer and activator of transcription 3; tin protoporphyrin; tristetraprolin; tumor necrosis factor; zinc protoporphyrin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / immunology
  • Anti-Inflammatory Agents / pharmacology
  • Cell Line
  • Cell Proliferation / drug effects
  • Cytokines / immunology
  • Cytokines / metabolism
  • Endotoxemia / immunology
  • Heme Oxygenase-1 / antagonists & inhibitors
  • Heme Oxygenase-1 / genetics
  • Heme Oxygenase-1 / immunology*
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Lipopolysaccharides
  • Liver / metabolism
  • Macrophages / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Nicotine / adverse effects
  • Nicotine / immunology
  • Nicotine / pharmacology*
  • Phosphorylation / drug effects
  • RNA Interference
  • RNA, Small Interfering
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Tristetraprolin / genetics
  • Tristetraprolin / immunology*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Lipopolysaccharides
  • RNA, Small Interfering
  • STAT3 Transcription Factor
  • Stat3 protein, mouse
  • Tristetraprolin
  • Tumor Necrosis Factor-alpha
  • Nicotine
  • Heme Oxygenase-1